July 22, 2024 — The effectiveness of CAR T cell therapy against ... discovered they could boost survival to 92% for patients with advanced Hodgkin lymphoma by adding the immunotherapy nivolumab ...

In a recent study published in Nature Cancer, researchers explore treatment resistance and relapse in T-cell acute ...

Yescarta – a CD19-directed genetically modified autologous T-cell ... non-Hodgkin lymphoma are diagnosed each year: roughly 5,500 of those are DLBCL and 330 are PMBCL. Overall survival rate ...

High cumulative doses of epipodophyllotoxins were associated with the highest risk for survivors of childhood cancer of ...

In this French multicentre case–control study, cases were adults (age ≥18 years) with RA fulfilling ACR-EULAR 2010 criteria in whom B-cell NHL or Hodgkin’s lymphoma developed after the diagnosis of RA ...

Researchers have found an increased frequency of severe maternal morbidity and obstetric complications among women who ...

Findings of a recent study indicate that NUP98 rearrangements can significantly impact outcomes in patients with acute myeloid leukemia (AML).

Overall response rate ... targeted CAR T-cell therapy in autoimmune diseases is underway and expected to initiate in the fourth quarter of 2024 MB-106 data in B-cell non-Hodgkin lymphoma (NHL ...

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...

Discover which therapies are expected to grab the PD/L-1 Market Share @ PD/L-1 Treatment Market Size ...

For example, the FDA in August used the accelerated approval process to clear the first T-cell receptor gene therapy for ...

For people 55 and over, AT&T offers unlimited talk, text, and data plans for $40 per month per line; however, only Florida residents are eligible for these plans. For those who don’t live in Florida, ...